Zumla A, Wang FS, Ippolito G, Petrosillo N, et al. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - achieving global consensus and visibility for cellular host-directed therapies. Int J Infect Dis 2020 May 17. pii: S1201-9712(20)30347.
PMID: 32425638